Pharmaceutical Technology: GigaGen works on recombinant polyclonal antibody against Covid-19

Biotechnology company GigaGen is working on a recombinant polyclonal antibody, recombinant anti-coronavirus 19 hyperimmune gammaglobulin (rCIG), as a Covid-19 treatment.

The therapy reproduces whole antibody repertoires of recovered patients, including antibodies that block further replication of the novel coronavirus.

Read the full story.